Jose A. Arranz
Madrid, MD 28007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Myocardial immune vulnerability unmasked after treatment with immune checkpoint inhibitors: a case report.
Journal: European heart journal. Case reports
Published: October 05, 2025
Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.
Journal: Oncoimmunology
Published: August 08, 2025
Patterns of treatment in first and subsequent lines in RCC in Spain. A real-world descriptive cross-sectional study.
Journal: Future oncology (London, England)
Published: August 07, 2025
Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations.
Journal: Cancers
Published: July 16, 2025
rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator's choice in patients with mCRPC.
Journal: Future oncology (London, England)
Published: June 02, 2025
Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.
Journal: Current oncology reports
Published: May 09, 2025
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.
Journal: Current oncology reports
Published: October 05, 2024
Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials.
Journal: Clinical genitourinary cancer
Published: September 06, 2024
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.
Journal: Cancer immunology research
Published: July 09, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D.
Journal: European urology oncology
Published: December 06, 2023
Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma.
Journal: European urology open science
Published: October 05, 2023
Endocrine Adverse Events Related To Immune Checkpoint Inhibitor Treatment: Relationship Between Antibodies and Severity of Thyroid Dysfunction.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: September 09, 2023
Last Updated: 09/26/2026